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Changes in laboratory parameters can be caused by physical, chemical, biological and other 
external factors, depending on physiological conditions, in most cases they have an adaptive nature, 
and it is not always possible to distinguish them from physiological fluctuations. At the same time, 
obvious shifts in laboratory parameters may indicate a violation of adaptation processes and damage 
of tissues and organs, despite the absence of clinical manifestations of a disease. 
________________________________________________________________________________
Introduction 
This article systematizes the evidence on 
the influence of environmental, nutritional, 
medicinal and other exogenous factors and 
physiological conditions on laboratory 
parameters of the hemostasis system, as well as 
violations of platelet hemostasis in 
inflammation. The material of the article will 
help to detect pre - pathology in clinically 
healthy individuals, address issues of early 
diagnosis, prognosis, evaluation of efficacy and 
safety of therapy, determine the degree of 
positive and negative effects of external and 
physiological factors, prevent misinterpretation 
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of laboratory parameters, diagnostic errors, 
adverse treatment consequences. 
All etiological factors of inflammation 
are divided into exogenous and endogenous 
ones. 
Exogenous (external) inflammatory 
factors include: amicroorganisms (viruses, 
bacteria, fungi); chemicals (acids, alkalis); 
animal organisms (worms, insects, protozoa);  
thermal factors (heat, cold); ionizing and 
ultraviolet rays;  mechanical factors (foreign 
bodies, rupture, pressure). 
           Endogenous (internal) inflammatory 
factors include those that occur in the body as a 
result of another disease:  inflammation can 
develop as a reaction to the tumor;  
inflammation can occur as a reaction to 
gallstones and urinary stones; cinflammation 
can occur as a reaction to a blood clot that has 
formed in the blood vessels.  antigen + antibody 
complexes, which are fixed in a specific organ. 
 The main causes of inflammation are:  
necrobiotic changes in tissues and cells that 
occur under the influence of exogenous 
physicochemical factors; malignancy of the 
body's own cells; invasion of foreign 
microorganisms or antigens, immunogens into 
the internal environment; loss of immunological 
tolerance to antigens of the body 
Experimental part 
Material and methods  
Study of the functional state of platelets 
To research the state of platelet hemostasis, 
adhesion, adenosine diphosphate (ADP) - 
aggregation of peripheral blood platelets in 
platelet-rich plasma were studied. Platelet 
counting was performed using a Goryaev 
counting chamber. The time of ADP 
aggregation was also determined. The degree of 
maximum platelet aggregation (Figure 1).  was 
investigated (expressed as a percentage 
difference between the initial number of 
platelets, which was taken as 100%, and the 
number of platelets 10 min after the addition of 
ADP solution to the sample); the degree of 
platelet adhesion (the difference between the 
initial number of platelets and the number of 
platelets after contact with glass under 
conditions of rotation on an electromagnetic 
stirrer for 5 min). 
 
  Figure 1. Platelet adhesion 
In patients with chronic inflammatory 
processes, thallium genes were also determined 
by the content of PV contained in poor platelet 
plasma using formalized donor platelets by the 
method of Evans et Osten in the modification of 
O.A. Tsyguleva. 
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The principle of the method is that the 
influence of the investigated PV on the 
aggregation of washed and formalin-fixed 
platelets of healthy individuals under the 
influence of ristocetin is determined. 
Quantitative determination is performed on the 
dilution curve of normal mixed platelet-free 
plasma. The method is based on the fact that 
platelets treated with a weak solution of 
formalin retain the ability to ristocetin - 
aggregation (in the presence of PV), but are not 
subject to other types of aggregation 
(spontaneous, under the influence of ADP, 
adrenaline, thrombin, etc.). 
Reagents. 
1. 3.8% solution of sodium citrate; 
2. Buffer solution (pH 7.6; 2 = KH2 
PO4; 8 02 NaCl, 8.8 = Na2HPO4 dissolved in 1 
liter of distilled water); 
3.Buffered EDTA 
(ethylenediaminetetraacetic acid) - formalin 
solution: 3 ml of 0.007 M (0.483%) EDTA, 5 
ml of 4% formalin solution, 2 ml of buffer, 10 
ml of distilled water; 
4. EDTA - buffer solution: 0.77 M 
EDTA (1 part) with buffer solution (49 parts); 
5. Ristocetin solution (10 mg per 1 ml of 
buffer). 
Preparation of suspension of washed 
fixed platelets of healthy people: 9 parts of 
venous blood of donors are mixed with 1 part of 
EDTA - formalin solution; in which blood is 
injected directly from a puncture needle. 
Centrifuge for 5 min at 1500 rpm to obtain 
platelet-rich plasma, in which hemolysis can be 
expressed. From this plasma, platelet-poor 
plasma is obtained by centrifugation for 20 min 
at 4000 rpm. Platelet-poor plasma is removed, 
and the platelet pellet is washed twice with 
EDTA buffer solution (4 times the volume by 
centrifugation each time for 10 min at 4000 
rpm). The buffer containing EDTA is removed 
by suction, and the platelet precipitate is diluted 
in a buffer solution without EDTA so that 1 μl 
contained about 200,000 Tr. 
Concentration of normal platelets: 
Normal formalized platelets can be preserved so 
as not to prepared them again each time. To do 
this, after washing with EDTA - buffer solution 
(twice) they are placed in phosphate buffer (pH 
7.4) with 0.01% sodium azide solution. 
The suspension is packaged in 3 ml 
sterile vials, rolled up and stored in a freezer (at 
-10 -12 ºC) for 2-3 months. If necessary, the 
contents of the vials are thawed; platelets are 
washed twice from the preservative solution 
with buffer without EDTO and used in the test. 
Preparation of platelet-free plasma of the 
subject. Blood is taken from a vein under 
siliconization conditions and mixed with 3.8% 
sodium citrate solution (9 :1). Centrifuge for 7 
minutes at 1500 rpm. Remove platelet-rich 
plasma, which is centrifuged for 20 min at 4000 
rpm. Platelet-poor plasma is transferred to 
another silicone or plastic tube and used in the 
test. 
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The course of the study. 
In 2 cuvettes for PEC with a working 
face of 5.65 and a volume of 2.5 ml, 1 ml of the 
suspension of washed normal platelets, 0.4 ml 
of platelet-free plasma of the subject and 0.4 ml 
of buffer without EDTА are injected. 
0.6 ml of buffer is injected into the 
control cuvette. Both cuvettes are placed in the 
PEC and at λ = 630 nm set the arrow of the PEC 
on "O" in the cuvette with the test sample, enter 
0.2 ml of ristocetin solution, mix, turn on the 
stopwatch. After 2 minutes, changes in the 
optical density of the test sample, which are 
associated with platelet aggregation under the 
influence of ristocetin, are recorded. 
Construction of the dilution curve. 
To quantify the presence of Willebrand 
factor in the studied plasma use a standard 
dilution curve obtained from a large group of 
healthy young people with normal platelet-free 
plasma. This plasma is diluted with buffer 
without EDTА from 1: 2 to 1:32, after which 
the washed normal platelets are introduced into 
each sample according to the above method is 
determined by ristocetin - platelet aggregation. 
The calculation point is the dilution of plasma at 
which ristocetin no longer causes platelet 
aggregation. This point corresponds to 2 - 3% 
presence in the environment of the Willebrand 
factor. The obtained data are plotted on 
logarithmic paper. With the correct construction 
of the curve in the white-logarithmic coordinate 
system has the form of a straight line. Using this 
curve, determine the presence of Willebrand 
factor in the test plasma. For greater accuracy, 
the latter can also be studied in 2 - 3 dilutions. 
1. The influence of exogenous and 
physiological 
2. factors on human adaptation processes. 
1. Hemostasis (Figure 2) system research 
indicators.  
     1.1 Bleeding time. Bleeding time is 
measured after the formation of a wound on the 
skin of the earlobe, the flesh of the nail phalanx 
of the finger, or the upper third of the palmar 




Figure 2. Vascular platelet hemostasis 
The increase in bleeding time is due to the 
influence of nutritional factors: vitamin C 
deficiency in food; hapten thrombocytopenia 
when taking certain products, physical factors: 
thrombocytopenia after exposure to ionizing 
radiation, chemical factors, thrombocytopenia 
after exposure to myelotoxic industrial, 
agricultural and household chemicals - fluorine 
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and its organic compounds, carbamines, 
chlorocysts; drugs: thrombocytopenia after 
exposure to myelotoxic drugs (cytostatics, 
nonsteroidal anti-inflammatory drugs; 
thrombocytopenia of immunoallergic (hapten) 
genesis after taking quinine, quinidine, 
digitoxin, PAS, sulfanilatide, zilfanilamites, 
zifanilamides, zifanilamides, zifanilamides, 
zifanilamides, zifanilamites, metronidazole, 
dipyridamole, penicillin, indomethacin, delagil, 
furosemide, in newborns whose mothers in the 
second and third trimesters took salicylates, 
sulfonamides, dipyridamole, metronidazole [1]. 
Reduction of bleeding time occurs under the 
influence of physiological factors: - pregnancy, 
III trimester, drugs of influence: - cancellation 
of anticoagulants.  Capillary resistance. 
A "cuff" test is usually used to study it. 
Normal values: the number of petechiae is not 
more than 10, with a diameter of not more than 
1 mm.  
Increasing the number and diameter of 
petechiae: 
1.Nutritional factors: deficiency of vitamins C 
and D in food. 
Platelet count 
1.2. Platelet ADP aggregation (Figure 3) 
characterizes the ability of platelets to aggregate 
in the presence of aggregating factors (ADP). 
 
Figure 3. ADP platelet aggregation 
Normal values: (according to the method of 
Baluda, 1996) 
Aggregation after 1 minute - 50 ± 3%,maximum 
aggregation - 66 ± 3%,  maximum aggregation 
time - 3-6 minutes, disaggregation start time - 
10 minutes,  the degree of disaggregation after 
25 minutes - 53%. 
Decreased platelet aggregation: 
1. Alimentary factors of influence : deficiency 
of vitamin B12 in food;  eating a bite. 
2. Physical factors of influence: validity of 
ionizing radiation. 
3. Drugs:  thrombocytopathy with the use of 
nonsteroidal anti-inflammatory drugs 
(salicylates, pyrazolone derivatives, 
butadolidine, brufen, ibuprofen, indomethacin, 
naproxen);  antispasmodics (papaverine, 
euphylline);  antibiotics (carbenicillin, 
penicillin, prostacyclin);  psychotropic drugs 
(neuroleptics aminazine, dipyridamole; 
tranquilizers imipramine, amitriptyline);  
barbiturates, anesthetics (ether, cyclopropane, 
nitrous oxide);  diuretics (phenothiazine 
derivatives, furosemide);  derivatives of 
nitrofurans, antihistamines (diazoline, 
diphenhydramine);  cytostatic agents 
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(vinblastine, vincristine);  massive blood 
transfusions and blood substitutes 
(reopolyglucin);  hormonal drugs (steroid 
hormones, insulin, anabolic steroids, 
vasopressin);  anti-calcium drugs (isoptin, 
corinfar.);  coronary dilators (curantil, sodium 
nitroprusside);  adrenoblockers (phentolamine, 
yohimbine);  fibrinolytics (streptokinase, 
urokinase); anticoagulants ticlopidine);  
derivatives of quinine (quinine, quinidine, 
quinacrine); vitamin preparations (nicotinic 
acid, tocopherol, cyanocobalamin, ascorbic 
acid, folic, pentothenic acids, pyridoxine);  other 
drugs (intensaine, anthurane, imidazole and its 
derivatives, prostaglandin E, forskolin, 
anagremide, cilostamide, naphthazar, miscleron, 
anginine, suloctidil). 
1.3. Ristomycin-platelet aggregation 
The method allows to detect the activity 
of Willebrand factor (Figure 4). A linear 
relationship has been established between the 
degree of ristomycin aggregation and the 
amount of Willebrand factor [2]. 
 
Figure 4. Platelet aggregation with Willebrand factor 
Normal values : the minimum aggregating dose 
of ristomycin is 0.6 ± 0.05 mg / ml 
Increased aggregation (reduced minimum 
aggregation dose): 
1. Drugs:  taking oral contraceptives, arteparon. 
Decrease in aggregation (increase in the 
minimum aggregation dose): 
1. Drugs: taking salicylates, penicillin, 
indomethacin, delagil, furosemide,  in newborns 
whose mothers took metronidazole, 
dipyridamole, salicylates during pregnancy (II 
and III trimesters). 
2.Coagulation hemostasis – acrocirculatory, 
secondary (Figure 5). 
2.1. The clotting time of unstabilized whole 
venous blood at 37оС. 
 
Figure 5. Coagulation hemostasis 
Normal values: 4-10 minutes 
Increased blood clotting time: 
1. Nutritional factors:  deficiency of vitamin K 
in food. 
2. Physical factors: validity of ionizing 
radiation. 
 3. Drugs:   treatment with heparin, direct-acting 
anticoagulants (phenylene, dicoumarin.). 
Reduction of blood clotting time: 
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1.Physiological factors: pregnancy, III trimester. 
2. Chemical factors:  validity of dioxins. 
3. Drugs: use of oral contraceptives (infecundin, 
bisecurin, rigevidon); taking psychotropic drugs 
(thioridazine, chlorprothixene, mepazin, 
thioproperazine, reserpine, raunatin);  large 
doses of ascorbic acid;  in newborns whose 
mothers took anticoagulants and salicylates 
during pregnancy (II and III trimesters). 
2.2. Cephalin time (partial thromboplastin time) 
Cephalium time is an indicator of the internal 
system of prothrombin activation (Figure 6). 
Determine the time of recalcification of platelet 
plasma in the presence of cephalin 
(phospholipid activator) [3]. Normal values: 65-
80 sec.  Increase in cephalin time: 
1. Chemical factors:  dioxin intoxication. 
2. Drugs: use of large doses of heparin; in 
newborns whose mothers took anticoagulants 
during pregnancy (II-III trimester). 
Kaolin-cephalin time (activated partial 
thromboplastin time) (APTT) 
Kaolin-cephalin time is an indicator of the 
internal system of prothrombin activation after 
the maximum activation of factors XI and XII. 
Determine the time of recalcification of platelet-
free plasma in the presence of kaolin (contact 
factor) and cephalin (phospholipid activator)[4]. 
 
Figure 6. Partial thromboplastin time 
Normal values: 38-65 sec.  
Increase in kaolin-cephalin time: 
1. Physiological factors: in newborns, especially 
premature. 
2. Drugs: use of large doses of heparin; - in 
newborns whose mothers took anticoagulants in 
the second and third trimesters. 
Reduction of kaolin-cephalin time: 
1.Physiological factors: pregnancy, III trimester. 
2.3. Prothrombin (thromboplastin) time  
(Figure 7). Prothrombin time is an indicator of 
the external activation system of prothrombin. It 
is widely used to monitor treatment with 
indirect anticoagulants because the study does 
not require venipuncture and can be performed 
often enough. Determine the clotting time of 
plasma with the addition of thromb oplastin and 
calcium chloride. 
 
Figure 7. Prothrombin (thromboplastin) time 
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Normal values depend on the activity of the 
thromboplastin used, so the prothrombin index 
(PI) is more often determined. 
          
PT = 12–20 sec; PI = 90–105% 
Increase in prothrombin time (PT) - decrease in 
prothrombin index (PI). 
1. Physiological factors: in newborns, especially 
for 2-3 days; in premature infants up to 2 weeks 
of age. 
2. Nutritional factors:  deficiency of vitamin K 
in food [5]. 
3.Chemical factors: intoxication with 
chloroform and other halogenated hydrocarbon 
compounds, phosphorus, dioxanes. 
4. Drugs: treatment with indirect anticoagulants, 
fibrinolytics, salicylates, novocephalin, 
citramon, ascofen, anabolic steroids, thiazide 
diuretics, iron supplements; in newborns whose 
mothers used indirect anticoagulants during 
pregnancy (II-III trimesters) (Figure 8). 
Decrease in prothrombin time (PT) - increase in 
prothrombin index (PI): 
1. Physiological factors: increased coagulation 
in pregnant women and during childbirth. 
2. Drugs:  overdose of vicasol. 
 
Figure 8. Activated partial thromboplastin, prothrombin, 
thrombin time 
2.2.4. Thrombin time 
Thrombin time is an indicator of the time of 
transition of fibrinogen to fibrin (Figure 9). The 
clotting time of blood plasma is determined by 




Figure 9. Thrombin time 
Normal values: about 15 sec. Plasma does not 
coagulate: 
1.Drugs:   treatment with heparin. 
2.2.5. Fibrinogen (Figure 10). 
Fibrinogen is a precursor of insoluble fibrin, 
determined by drying the convolution formed 
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by adding a standard activity of thrombin 
solution to a certain volume of plasma (Figure 
11) [6]. 
 
Figure 10. Fibrinogen formation 
Normal values: 1.8–3.5 g / l. 
Increasing the concentration of fibrinogen: 
1.Physiological factors: menstruation;  
pregnancy, III trimester. 
2. Nutritional factors: deficiency of vitamin C in 
food. 
3. Physical factors:  radiation exposure. 
4. Chemical factors: intoxication with salvarsan, 
chloroform. 
       
Figure 11. Structure of fibrinogen    
Decreased fibrinogen concentration: 
1. Chemical factors: poisoning by hepatotropic 
poisons; chlorinated naphthalenes, chlorinated 
hydrocarbons (chloroform, carbon 
tetrachloride), azo dyes, benzene, styrene, 
phosphorus, arsenic, heavy metals, 
organophosphorus pesticides. 
2. Drugs: taking phenobarbital, streptokinase, 
urokinase. 
2.2.6. Fibrinase activity 
Fibrinase, or Factor XIII, or fibrin stabilizing 
factor, is found in the vascular wall, platelets, 
erythrocytes, kidneys, lungs, muscles, placenta, 
and binds fibrin monomers into a fibrin polymer 
[8].  Normal values: 35 ± 5 s 
Decreased fibrinase activity: 
1. Physiological factors:  pregnancy. 
2. Nutritional factors:  deficiency of vitamins in 
food. 
3. Physical factors:  ionizing radiation. 
2.3. Fibrinolytic activity of blood (Figure 12) 
2.3.1. Time of lysis of euglobulins 
The lysis time of the euglobulin fraction (devoid 
of antiplasmin) of plasma depends on the 
amount of fibrinogen, plasmin, plasminogen 
activators. The time of spontaneous lysis of the 
convolution obtained from the euglobulin 
fraction of platelet plasma when adding a 
solution of calcium chloride is determined [9]. 
Normal values: 100-300 sec. 
Activation of fibrinolysis (lysis time of 
euglobulins is reduced): 
1. Therapeutic measures: surgical interventions;  
taking adrenaline, dextrin, streptokinase and 
other fibrinolytics. 
Inhibition of fibrinolysis (euglobulin lysis time 
is extended): 
1.   Physiological factors:  pregnancy;  in 
premature infants. 
2.  Drugs:  taking trasilol and other 
antiproteases, oral contraceptives. 




Figure 12. Fibrinolytic activity of blood 
2.3.2. Fibrin degradation products (PDF) 
PDFs are normally contained in very small 
quantities and are not defined by commonly 
used methods. At increase of concentration of 
PDF to 10 mkg / ml ethanol and protamine 
sulfate tests become positive (observe formation 
of a deposit in blood serum after addition to it of 
solution of protamine sulfate or ethanol). 
Determination of PDF can also be performed 
using antibodies against fibrin / fibrinogen 
fragments (Figure 13) [10]. 
 Positive test: 
1. Physiological factors: pregnancy, III 
trimester. 
2.     Drugs:   treatment with fibrinolytic drugs. 
 





Figure 14. Protein C 
 
Figure 15. Activation of Protein C 
Protein C is an active vitamin K-dependent 
anticoagulant (Figure 15) [11]. Normal values: 
about 1 g / l. Reducing the content of protein C: 
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1.Drugs: treatment with anticoagulants of 
indirect action (Figure 
16).
 
Figure 16. Anticoagulants 
2.4.1. Antithrombin III (BP III) 
         Plasma antithrombin (Figure 17) activity 
primarily depends on BP III and, to a lesser 
extent, on α2-macroglobulin, α1-antitrypsin, 
C1-esterase inhibitor and others. This test is 
important for the control of heparin therapy. 
         BP III is determined after incubation of a 
mixture of serum and thrombin solution of 
standard activity. The final thrombin is 
determined in the thrombin-fibrinogen reaction. 
 
Figure 17. Antithrombin III (BP III) 
Normal values: 75–125% (100% is the 
antithrombin activity of whole donor plasma). 
Concentration: 20–50 mg / dl 
Increasing the activity of AT111: 
1. Physiological factors:  during menstruation. 
2. Nutritional factors: vitamin K deficiency in 
food. 
3. Drugs: use of anabolic drugs; taking 
anticoagulants of indirect action. 
Decreased activity of AT111: 
1. Physiological factors: the middle of the 
menstrual cycle; the last months of pregnancy; 
postpartum period. 
2. Drugs:  long-term use of oral contraceptives, 
estrogens; long-term treatment with 
corticosteroids; use of clofibrate, 
norepinephrine, rifampicin; treatment with L-
asparaginase; treatment with large doses of 
heparin (with a decrease in blood pressure of III 
more than 25%, the effectiveness of heparin 
therapy is significantly reduced). 
Plasma tolerance to heparin. Plasma 
recalcification time and convolution formation 
after heparin injection into the plasma are 
measured. The indicators of this test allow us to 
judge the interaction of coagulation and 
anticoagulation mechanisms of the blood 
coagulation system. Normal values: 11–16 min. 
         Reducing the clotting time means an 
increase in plasma tolerance to heparin and 
indicates activation of the coagulation system. 
An increase in clotting time means a decrease in 
plasma tolerance to heparin and indicates an 
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increase in anticoagulant activity, or a 
deficiency of coagulation factors [12]. 
  Increasing plasma tolerance to heparin: 
1. Physiological factors: the last months of 
pregnancy. 
Decreased plasma tolerance to heparin. 
1. Drugs: taking anticoagulants of direct 
(heparin) and indirect (phenylin, dicoumarin) 
action. 
         3. Influence of inflammatory process on 
indicators of thrombocyte link of hemostasis 
and their disturbance at chronic inflammation 
          Currently, there is so much information 
about the complications of many inflammatory 
and non-inflammatory diseases, disorders of 
systemic and local microcirculation, thrombosis 
and thromboembolism. Including 
microcirculation disorders are observed in 
inflammatory diseases of CO. Endothelial 
activation and dysregulation of endothelial and 
dendritic cell relationships have been found to 
accelerate the development of atherosclerosis 
and cardiovascular disease, because the 
adhesion and migration of dendritic cells 
enhance atherogenesis (Figure 18). Inhibition 
of NO synthesis by endothelial cells, hypoxia, 
oxidized fine LP, tumor necrosis factor (TNF) 
in inflammation also increase the adhesion and 
migration of dendritic cells (Figure 19). 
 
Figure 18. Аtherogenesis 
 
 
Figure 19. Adhesion and migration of dendritic cells 
As a result, the interaction of activated 
endothelial cells and inflammatory cells is 
extremely complicated (Figure 20). Therefore, 
the study of the parietal effects of the 
endothelium is very important [13]. An increase 
the level of VFW in blood plasma is considered 
to be a marker of endothelial activation and / or 
damage. 




Figure 20. Аtherosclerosis in the inflammatory process 
By its nature, the von Willebrand factor 
is a glycoprotein (from 500,000 to 2 million 
daltons) (Figure 21). The FW subunits contain 
binding domains to the glycoprotein receptors 
Tr, collagen, heparin, coagulation factor V111 
[14]. The main object of FW synthesis is 
endothelial cells. In this case, most of the 
synthesized FW is deposited in the granules of 
endothelial cells-cells of Veibel-Palade and, 
upon activation of cells is able to be rapidly 
released into the extracellular environment - 
into the blood. 
 
Figure 21. Von Willebrand factor 
The role of FW in the circulation 
consists of the transport of the coagulation 
factor procoagulant V111, which ensures its 
stability and accumulation at the sites of 
vascular damage and thrombosis. However, the 
most significant value of FW is its participation 
in vascular - TR interaction. At the stages of 
adhesion, flattening and aggregation of Tr, FW 
functions as a "bridge" between the 
subendothelial structures of the damaged 
vascular wall and Tr, as well as between the 
other ones. Currently, there are two approaches 
to the determination of FW: 1) determination of 
the level of FW antigen by using specific 
antibodies; 2) by ristocetin-induced aggregation 
of standard or formalized Tr. 
For some diseases, the diagnostic value 
of FW as a marker of endothelial dysfunction 
has been proved.  This was first shown by 
Boneu B. and co-authors (1975), who observed 
an increased concentration of FW in ischemic 
lesions of the extremities and sepsis. It was also 
shown an increase the level of FW in the blood 
plasma of patients with hypertension, ischemic 
stroke, pulmonary hypertension. 
It was observed decreased plasma FW 
levels in patients after thrombolysis, who used 
tissue plasminogen activator. 
In addition, there are indications on the 
shift in the functioning of other links of 
hemostasis in inflammatory diseases 
(prostaglandins, prostacyclin, thromboxane A2 
(TxA2), etc. in the literature sources [15], [16]. 
It is known that cyclic endoperoxides, which are 
formed due to the activation of lipid 
peroxydation in inflammatory processes, act as 
a substrate for of TXA2 synthesis in Tr and 
prostacyclin in vascular endothelium. TxA2 is a 
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powerful activator of Tr aggregation and causes 
vascular spasm, whereas prostacyclin, in 
contrast, inhibits Tr aggregation and dilates 
blood vessels. Changes in the balance between 
TxA2 and prostacyclin towards prostacyclin 
cause activation of the coagulation system and 
thrombosis. Particularly,it is found  a tendency 
to decrease the level of plasminogen activator 
and increase the content of its inhibitor, as well 
as the antigen U111 PV and ristocetin 
aggregation Tr in patients with chronic 
glomerulonephritis. In patients with chronic 
nephritis, an association has been found 
between the  increased Tr aggregation function 
and oxidative "stress" (increased levels of DC 
and MDA in the blood). Deterioration of local 
microcirculation was found in children with 
vasomotor rhinitis. The fibrinolytic system in 
patients with lupus nephritis is depleted first by 
the local renal vascular channel, and then by the 
systemic, depending on the severity of the 
disease. Studies of the functions of 
microcirculatory hemostasis in patients with 
bronchial asthma have shown an increase in the 
amount of Tr, their ability to respond to the 
action of aggregating agents, violation of the 
content of TxA2. 
In patients with steroid-dependent 
bronchial asthma and chronic obstructive 
pulmonary disease, the authors observed 
activation of total fibrinolytic activity of blood 
plasma until the development of disseminated 
intravascular coagulation syndrome. In patients 
with inflammation of the skin, both allergic 
contact dermatitis and atopic damage, or due to 
skin irritation, the expression of CS-1 
fibronectin was found in the endothelial cells of 
inflamed vessels. In patients with psoriasis, 
there is an increase in the activity of Tr 
hemostasis on the background of reduced 
fibrinolytic activity of the blood, and at the 
same time Tr factors are significantly involved 
in the implementation of psoriatic inflammation.  
The authors identified a correlation 
relationship between endothelial activation and 
release of adhesion molecules, impaired 
hemostasis, immunity and indicators that 
characterize the development of atherosclerosis 
in cases of rheumatoid arthritis. In patients with 
appendicitis there are adverse disorders of the 
LP spectrum of Tr membranes, which increase 
their Tr potential. Obliterative endarteritis is 
accompanied by a significant increase in the 
adhesive-aggregation properties of Tr in the 
lesion with a high risk of developing a 
generalized form of hemostasis. 
In hypertension Tr endothelial 
dysfunction occurs with the involvement of 
proinflammatory cytokines, which indicates the 
immune-inflammatory nature of endothelial 
damage in high blood pressure[18]. In case of 
insulin-dependent diabetes mellitus, an increase 
of spontaneous aggregation was found. It is 
believed that these processes depend on the 
deficiency of NO secretion by damaged 
endothelial cells. 
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In case of STI lesions, which can cause 
inflammation of the CO, disorders of the 
hemostasis system and signs of endothelial 
lesions are also observed. 
The works of J.I. Arkhipova and co-
authors showed that most hemoblastoses and 
aplastic anemias are complicated by immune 
compromise, the development of mycoses in 
combination with hemorrhagic syndrome. 
Bleeding is caused not only by Tr-penia due to 
aplasia of the bone marrow, but also by the 
tropism of the mycosis pathogen to blood 
vessels. Some fungi, including yeast and, 
especially, mold, are able to invade blood 
vessels with the development of necrotizing 
angiitis, which is manifested by necrosis, heart 
attacks, hemorrhages in various cavities, organs 
and tissues. 
          In case of secondary syphilis, indicators 
of spontaneous and inductive aggregation of Tr 
appear, as well as EF, which characterizes 
hemostasiological endothelial dysfunction [16]. 
Patients with endothelial inflammation have 
reduced fibrinolytic properties and develop 
resistance to thrombolysis, which plays an 
important role in the occurrence of heart attacks 
[17]. 
     Thrombin, activated during the inflammatory 
response, acts as an important mediator of 
neutrophil-dependent damage, joining the 
multicomponent inflammatory cascade system 
as an important link between inflammation and 
thrombosis. 
Results and discussion 
             State of platelet of hemostasis in 
patients with chronic inflammatory process of 
genitals.  
For laboratory diagnosis of the activity 
of the inflammatory process and the prognosis 
of complications, the assessment of the 
functional state of platelets is of great 
importance.  
Therefore, in patients with chronic 
inflammatory process of the genitals gene, we 
studied the indicators of adhesive-aggregation 




Figure 22. Platelet adhesion, activation and 
aggregation on exposed subendothelium, for example at a 
wound site.  
The relative level of Von Willebrand factor 
(VWF), the platelet component of which 
characterizes platelet aggregation, was also 
determined, and the vascular component is 
considered a marker of endothelial damage[19].  
As a result of the study, an increase in the 
intensity of platelet adhesion (Table.1) was 
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found in men of the 2nd group by 1.2 times (p 
<0.05) and in women of the 3rd group 1.4 times. 
Table 1. Indicators of platelet hemostasis and von 
Willebrand factor in patients with chronic inflammatory 





















M 40,5±4,9 15,7±2,8 17,9±5,3 100 
W 38,9±4,1 14,9±3,6 20,2±4,9 100 
К 
2 
M 41,2±5,3 15,2±3,3 18,8±4,8 100 
W 40,0±3,8 14,3±5,3 21,1±7,2 100 
К 
3 
M 42,0±3,8 14,8±3,6 20,7±5,3 100 












































Note. * - p <0.05; compared to control 
The time of onset of platelet ADP 
aggregation was significantly reduced in men of 
the 1st and 2nd groups in 1.9 and 1.6 times  
(p <0.05), respectively, and in women of the 
2nd and 3rd groups in 1.5 (p <0.05) and 1.6 (p 
<0.05) times compared to K. 
The intensity of maximal ADP platelet 
aggregation significantly exceeded that in all 
groups of patients.  
Thus, in men of the 1st, 2nd and 3rd 
groups, this indicator was increased by 2.0 (p 
<0.05) times.  
In women of the 1st, 2nd and 3rd groups, 
the degree of maximal platelet ADP aggregation 
was increased by 2.0, 1.7 and 1.6 times (p 
<0.05), respectively. 
We observed that a certain level of VWF 
in all groups of people decreased and ranged 
from 30 to 62% of this control group (100%). 
Given the fact that the vascular component of 
VWF is a marker of the functional state of the 
vascular endothelium, we can assume that in 
patients with chronic inflammatory process of 
the genitals there was damage to endothelial 
cells, endothelial dysfunction with reduced 
VWF production. 
When analyzing the function of platelet 
counts in groups of patients depending on the 
type of inflammatory pathogen (table 4.2) 
revealed a probable increase in platelet adhesion 
in all groups except the 5th with (viral infection) 
on average 1.4 times (p <0,05) ; reduction of 
aggregation time by 1.3 times (p <0.05); 
increase in maximum aggregation by 1.9-2.2 
times (p <0.05). 
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We watched as the relative level of VWF 
plasma levels probably decreased in all groups 
of patients with different sexual infections 2.4-
3.2 times.  
The decrease in this indicator in patients 
of group 4 with chlamydial infection was the 
most significant (p <0.05), compared with K, 1-
3 and 5-6 groups. 
           Table 2. Indicators of platelet (PLT) hemostasis 
and the content of von Willebrand factor in the plasma of 




















































































   1. * - p <0.05 compared with the control group 
2. ^ - p <0.05, compared to all other groups 
In general, disorders of adhesion-
aggregation functions of platelets occurred in 
the direction of increasing thrombogenic 
potential, while the relative level of von 
Willebrand factor in patients with group 4 with 
(chlamydial infection) VWF decreased (p 
<0.05).  
This can lead to a disorder of regulation 
of the vascular-platelet hemostasis system, 
primarily in the direction of increase with a 
possible subsequent decrease in the activity of 
primary hemostasis due to depletion of von 
Willebrand factor and the consumption of 
circulating platelet pool. 
Endothelial dysfunction and platelet 
dysfunction, on the one hand, leads to limited 
access of drugs to the lesion, and on the other 
hand, does not exclude the possibility of 
complications from the blood coagulation 
system. 
Therefore, the question arises whether 
chronic inflammatory processes of the genitals 
can play a role in the development of platelet 
disorders of hemostasis.  
To answer this question, we observed 
that the obtained data correlated with indicators 
that characterize inflammatory processes: local - 
in the source of inflammation, as well as in the 
circulating blood system. 
It was also interesting to trace the 
associations of shifts in lipid metabolism and 
adhesion-aggregation function of platelets and 
the relative level of von Willebrand factor in the 
plasma of patients with chronic inflammatory 
diseases of the genitals.  
We showed that the shift in the 
concentration of Low-density lipoprotein 
cholesterol (LDL-C) had strong feedback with 
the amount of PLT per unit volume of blood (r 
= -0.73) (Table 3), the time of onset of ADP 
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aggregation PLT (r = -0, 52) and the relative 
level of VWF in blood plasma (r = -0.52), (p 
<0.05).  
The shift in the concentration of total 
cholesterol had strong feedback with the amount 
of  PLT per unit volume of blood (r = -061), the 
time of onset of ADP aggregation PLT (r = -
0.74), the relative level of VWF in blood plasma 
(r = -0.86), as well as a direct strong relationship 
with the intensity of maximum aggregation PLT 
(r = +0.89), (p <0.05). 
That is, an increase in the concentration 
of LDL-C and total cholesterol was associated 
with a decrease in the amount for VWF per unit 
volume of blood, acceleration and increase in 
the intensity of ADP aggregation of PLT and a 
decrease in the relative level of VWF. 
At the same time, the value of the 
concentration of High-density lipoprotein 
cholesterol (HDL-C) had direct strong 
correlations with the number of PLT per unit 
volume of blood (r = +0.73), the time of onset 
of ADP aggregation PLT (r = +0.51), relative 
the level of VWF in plasma (r = +0.64), and 
strong feedback (r = -0.63) (p <0.05) with the 
intensity of maximum ADP aggregation PLT. 
This means that the increase in HDL-C 
was associated with an increase in PLT per unit 
volume of blood, probably due to a decrease in 
their consumption, a decrease in the rate and 
intensity of PLT aggregation, normalization of 
VWF levels in blood plasma. 
 
Table 3. Correlation coefficients (r) of lipid 
metabolism and platelet count of hemostasis and the 
content of von Willebrand factor in blood plasma in 


































0,73* 0,51* -0,63* 0,64* 
Note. * - p <0.05, compared with the control 
group. 
In the surveyed individuals with the 
persistence of various agents of sexually 
transmitted infections, the probable strong 
feedback of the concentration of total 
cholesterol (CH) in the blood plasma and the 
time of onset of ADP aggregation (r = -0.79) 
and the relative content of VWF (r = -0, 96) (p 
<0.05), as well as strong direct connections with 
the maximum aggregation PLT (r = +0.94) (p 
<0.05) (Table 4).  
That is, the level of total cholesterol was 
associated with an acceleration and increase in 
ADP-aggregation of PLT and with a decrease in 
the relative level of VWF in blood plasma. 
Similar associations were observed with regard 
to the concentration of malonic dialdehyde 
(MDA) in blood plasma.  
This indicator had strong feedback with 
the time of onset of ADP aggregation PLT (r = -
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0.84) and the relative level of VWF (r = -0.94), 
as well as strong direct relationships with the 
intensity of ADP aggregation (r) = -0.97). 
Table 4. Correlation coefficients (r) of lipid metabolism 
and platelet count of hemostasis and the content of von 
Willebrand factor in blood plasma in subjects with 















n of CH,  
mmol l-1 
-0,79* 0,94* -0,96* 
Concentratio








Note. * - p <0.05, compared with the control 
group 
Conclusions  
Thus, the study found that increasing the 
level of proatherogenic substances in blood 
plasma (total cholesterol, low-density 
lipoprotein cholesterol, malonic dialdehyde) 
increases the aggregative activity of platelets 
and reduces the level of von Willebrand factor. 
At the same time, the increase in 
antiatherogenic substances high-density 
lipoprotein cholesterol (HDL-C) reduces 
platelet aggregation and increases the level of 
von Willebrand factor in blood plasma. 
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